Literature DB >> 1333043

Activation of the phosphoenolpyruvate carboxykinase gene retinoic acid response element is dependent on a retinoic acid receptor/coregulator complex.

R K Hall1, D K Scott, E L Noisin, P C Lucas, D K Granner.   

Abstract

The accessory factor 1 (AF1) element is an upstream transcriptional control region that plays a role in the response of the phosphoenolpyruvate carboxykinase (PEPCK) gene to both glucocorticoids and retinoic acid. We demonstrate here that retinoic acid receptor alpha (RAR alpha) binds to a sequence within the AF1 element, TGACCT (site B), that is a consensus retinoic acid response element (RARE) half-site. A similar DNA sequence, TGGCCG (site C), located 1 bp downstream of site B, is not involved in the binding of RAR alpha monomers or dimers but is required for the constitution of a functional RARE. Site C is also required for the formation of a complex involving RAR alpha and a liver nuclear factor designated CR, for coregulator. Mutational analysis of the AF1 element shows that the RAR alpha/CR complex is the trans-acting unit that mediates the retinoic acid response of the PEPCK gene. Another member of the retinoid receptor family, retinoid X receptor alpha (RXR alpha), can also form a complex with RAR alpha and the AF1 element. Several observations, including the observation that RXR alpha antibody interacts with CR, indicate that RXR alpha and CR are identical or closely related proteins. Through RXR alpha forms a complex with RAR alpha and the AF1 element, we demonstrate that the AF1 element is functionally distinguishable from a retinoid X response element. Taken together, our results show that the AF1 element contains an RARE that mediates a retinoic acid response by binding an RAR alpha/coregulator complex; this coregulator is presumably RXR alpha.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1333043      PMCID: PMC360490          DOI: 10.1128/mcb.12.12.5527-5535.1992

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  49 in total

1.  Half-site spacing and orientation determines whether thyroid hormone and retinoic acid receptors and related factors bind to DNA response elements as monomers, homodimers, or heterodimers.

Authors:  B M Forman; J Casanova; B M Raaka; J Ghysdael; H H Samuels
Journal:  Mol Endocrinol       Date:  1992-03

2.  The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors.

Authors:  A M Näär; J M Boutin; S M Lipkin; V C Yu; J M Holloway; C K Glass; M G Rosenfeld
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

3.  Identification of nuclear factors that enhance binding of the thyroid hormone receptor to a thyroid hormone response element.

Authors:  M B Murray; H C Towle
Journal:  Mol Endocrinol       Date:  1989-09

4.  A rapid, sensitive, and inexpensive assay for chloramphenicol acetyltransferase.

Authors:  S K Nordeen; P P Green; D M Fowlkes
Journal:  DNA       Date:  1987-04

5.  Baculovirus-mediated expression of the human vitamin D receptor. Functional characterization, vitamin D response element interactions, and evidence for a receptor auxiliary factor.

Authors:  P N MacDonald; C A Haussler; C M Terpening; M A Galligan; M C Reeder; G K Whitfield; M R Haussler
Journal:  J Biol Chem       Date:  1991-10-05       Impact factor: 5.157

6.  Specificity of a retinoic acid response element in the phosphoenolpyruvate carboxykinase gene promoter: consequences of both retinoic acid and thyroid hormone receptor binding.

Authors:  P C Lucas; B M Forman; H H Samuels; D K Granner
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

7.  Characterization of three RXR genes that mediate the action of 9-cis retinoic acid.

Authors:  D J Mangelsdorf; U Borgmeyer; R A Heyman; J Y Zhou; E S Ong; A E Oro; A Kakizuka; R M Evans
Journal:  Genes Dev       Date:  1992-03       Impact factor: 11.361

8.  9-cis retinoic acid is a high affinity ligand for the retinoid X receptor.

Authors:  R A Heyman; D J Mangelsdorf; J A Dyck; R B Stein; G Eichele; R M Evans; C Thaller
Journal:  Cell       Date:  1992-01-24       Impact factor: 41.582

9.  Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently.

Authors:  M Leid; P Kastner; R Lyons; H Nakshatri; M Saunders; T Zacharewski; J Y Chen; A Staub; J M Garnier; S Mader
Journal:  Cell       Date:  1992-01-24       Impact factor: 41.582

10.  Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling.

Authors:  S A Kliewer; K Umesono; D J Mangelsdorf; R M Evans
Journal:  Nature       Date:  1992-01-30       Impact factor: 49.962

View more
  23 in total

1.  Characterization of the human liver fructose-1,6-bisphosphatase gene promoter.

Authors:  B Herzog; M Waltner-Law; D K Scott; K Eschrich; D K Granner
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

2.  In pursuit of genes of glucose metabolism.

Authors:  Daryl K Granner
Journal:  J Biol Chem       Date:  2015-07-24       Impact factor: 5.157

3.  Synergistic transcriptional activation of the mouse urokinase plasminogen activator (uPA) gene and of its enhancer activator protein 1 (AP1) site by cAMP and retinoic acid.

Authors:  R Mira-Y-Lopez; S Jaramillo; Y Jing
Journal:  Biochem J       Date:  1998-05-01       Impact factor: 3.857

Review 4.  Transcriptional control of genes that regulate glycolysis and gluconeogenesis in adult liver.

Authors:  F P Lemaigre; G G Rousseau
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

5.  A pleiotropic element in the medium-chain acyl coenzyme A dehydrogenase gene promoter mediates transcriptional regulation by multiple nuclear receptor transcription factors and defines novel receptor-DNA binding motifs.

Authors:  M E Carter; T Gulick; D D Moore; D P Kelly
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

6.  Antiglucocorticoid activity of hepatocyte nuclear factor-6.

Authors:  C E Pierreux; J Stafford; D Demonte; D K Scott; J Vandenhaute; R M O'Brien; D K Granner; G G Rousseau; F P Lemaigre
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

7.  Anti-tumor effect in human lung cancer by a combination treatment of novel histone deacetylase inhibitors: SL142 or SL325 and retinoic acids.

Authors:  Shaoteng Han; Takuya Fukazawa; Tomoki Yamatsuji; Junji Matsuoka; Hiroyuki Miyachi; Yutaka Maeda; Mary Durbin; Yoshio Naomoto
Journal:  PLoS One       Date:  2010-11-04       Impact factor: 3.240

8.  The NF-kappa B and Sp1 motifs of the human immunodeficiency virus type 1 long terminal repeat function as novel thyroid hormone response elements.

Authors:  V Desai-Yajnik; H H Samuels
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

9.  Transcriptional regulation of the phosphoenolpyruvate carboxykinase gene by cooperation between hepatic nuclear factors.

Authors:  O Yanuka-Kashles; H Cohen; M Trus; A Aran; N Benvenisty; L Reshef
Journal:  Mol Cell Biol       Date:  1994-11       Impact factor: 4.272

10.  Retinoic acid-mediated activation of HNF-3 alpha during EC stem cell differentiation.

Authors:  A Jacob; S Budhiraja; X Qian; D Clevidence; R H Costa; R R Reichel
Journal:  Nucleic Acids Res       Date:  1994-06-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.